You have free access to this content

Hepatology

Cover image for Vol. 52 Issue 4

October 2010

Volume 52, Issue 4

Pages 1177–1526

  1. Master's Perspective

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Original Articles
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Steatohepatitis/ Metabolic Liver Disease
    8. Steatohepatitis/Metabolic Liver Disease
    9. Hepatobiliary Malignancies
    10. Autoimmune, Cholestatic and Biliary Disease
    11. Liver Failure/Cirrhosis/Portal Hypertension
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Rapid Communication
    15. Diagnostic and Therapeutic Advances in Hepatology
    16. Reviews
    17. Hepatology Elsewhere
    18. Image of the Month
    19. Correspondence
    1. You have free access to this content
  2. Editorials

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Original Articles
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Steatohepatitis/ Metabolic Liver Disease
    8. Steatohepatitis/Metabolic Liver Disease
    9. Hepatobiliary Malignancies
    10. Autoimmune, Cholestatic and Biliary Disease
    11. Liver Failure/Cirrhosis/Portal Hypertension
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Rapid Communication
    15. Diagnostic and Therapeutic Advances in Hepatology
    16. Reviews
    17. Hepatology Elsewhere
    18. Image of the Month
    19. Correspondence
    1. You have free access to this content
      The next step for taribavirin (pages 1185–1188)

      Paul Y. Kwo and Rakesh Vinayek

      Version of Record online: 28 SEP 2010 | DOI: 10.1002/hep.23957

    2. You have free access to this content
  3. Original Articles

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Original Articles
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Steatohepatitis/ Metabolic Liver Disease
    8. Steatohepatitis/Metabolic Liver Disease
    9. Hepatobiliary Malignancies
    10. Autoimmune, Cholestatic and Biliary Disease
    11. Liver Failure/Cirrhosis/Portal Hypertension
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Rapid Communication
    15. Diagnostic and Therapeutic Advances in Hepatology
    16. Reviews
    17. Hepatology Elsewhere
    18. Image of the Month
    19. Correspondence
    1. You have free access to this content
      Histologic outcomes in hepatitis C–infected patients with varying degrees of virologic response to interferon-based treatments (pages 1193–1200)

      Paul J. Pockros, Fayez M. Hamzeh, Paul Martin, Ellen Lentz, Xiaolei Zhou, Sugantha Govindarajan and Anna S. Lok

      Version of Record online: 16 JUN 2010 | DOI: 10.1002/hep.23809

  4. Viral Hepatitis

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Original Articles
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Steatohepatitis/ Metabolic Liver Disease
    8. Steatohepatitis/Metabolic Liver Disease
    9. Hepatobiliary Malignancies
    10. Autoimmune, Cholestatic and Biliary Disease
    11. Liver Failure/Cirrhosis/Portal Hypertension
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Rapid Communication
    15. Diagnostic and Therapeutic Advances in Hepatology
    16. Reviews
    17. Hepatology Elsewhere
    18. Image of the Month
    19. Correspondence
    1. You have free access to this content
      Randomized trial of peginterferon alfa-2b and ribavirin for 48 or 72 weeks in patients with hepatitis C virus genotype 1 and slow virologic response (pages 1201–1207)

      Maria Buti, Yoav Lurie, Natalia G. Zakharova, Natalia P. Blokhina, Andrzej Horban, Gerlinde Teuber, Christoph Sarrazin, Ligita Balciuniene, Saya V. Feinman, Rab Faruqi, Lisa D. Pedicone and Rafael Esteban

      Version of Record online: 30 JUN 2010 | DOI: 10.1002/hep.23816

    2. You have free access to this content
      Virologic response rates of weight-based taribavirin versus ribavirin in treatment-naive patients with genotype 1 chronic hepatitis C (pages 1208–1215)

      Fred Poordad, Eric Lawitz, Mitchell L. Shiffman, Tarek Hassanein, Andrew J. Muir, Bruce R. Bacon, Jamie Heise, Deanine Halliman, Eric Chun and Janet Hammond

      Version of Record online: 30 JUN 2010 | DOI: 10.1002/hep.23827

    3. You have free access to this content
      Potential role for Interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection (pages 1216–1224)

      Jason Grebely, Kathy Petoumenos, Margaret Hellard, Gail V. Matthews, Vijayaprakash Suppiah, Tanya Applegate, Barbara Yeung, Phillipa Marks, William Rawlinson, Andrew R. Lloyd, David Booth, John M. Kaldor, Jacob George and Gregory J. Dore

      Version of Record online: 29 JUL 2010 | DOI: 10.1002/hep.23850

    4. You have free access to this content
      Risk factors for infection during treatment with peginterferon alfa and ribavirin for chronic hepatitis C (pages 1225–1231)

      Robert Roomer, Bettina E. Hansen, Harry L. A. Janssen and Robert J. de Knegt

      Version of Record online: 29 JUL 2010 | DOI: 10.1002/hep.23842

    5. You have free access to this content
      A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B (pages 1232–1241)

      Henry Lik-Yuen Chan, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Chi-Hang Tse, Hoi-Yun Chan and Joseph Jao-Yao Sung

      Version of Record online: 11 JUN 2010 | DOI: 10.1002/hep.23803

    6. You have free access to this content
      Glucosidase inhibition enhances presentation of de–N-glycosylated hepatitis B virus epitopes by major histocompatibility complex class I in vitro and in woodchucks (pages 1242–1250)

      Pamela A. Norton, Stephan Menne, Gomathinayagam Sinnathamby, Lucy Betesh, Paul J. Cote, Ramila Philip, Anand S. Mehta, Bud C. Tennant and Timothy M. Block

      Version of Record online: 16 JUN 2010 | DOI: 10.1002/hep.23806

    7. You have free access to this content
  5. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Original Articles
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Steatohepatitis/ Metabolic Liver Disease
    8. Steatohepatitis/Metabolic Liver Disease
    9. Hepatobiliary Malignancies
    10. Autoimmune, Cholestatic and Biliary Disease
    11. Liver Failure/Cirrhosis/Portal Hypertension
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Rapid Communication
    15. Diagnostic and Therapeutic Advances in Hepatology
    16. Reviews
    17. Hepatology Elsewhere
    18. Image of the Month
    19. Correspondence
    1. You have free access to this content
    2. You have free access to this content
      Defective bone morphogenic protein signaling underlies hepcidin deficiency in HFE hereditary hemochromatosis (pages 1266–1273)

      John D. Ryan, Eleanor Ryan, Aurelie Fabre, Matthew W. Lawless and John Crowe

      Version of Record online: 30 JUN 2010 | DOI: 10.1002/hep.23814

    3. You have free access to this content
      I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease (pages 1274–1280)

      Luca Valenti, Anna Alisi, Enrico Galmozzi, Andrea Bartuli, Benedetta Del Menico, Arianna Alterio, Paola Dongiovanni, Silvia Fargion and Valerio Nobili

      Version of Record online: 30 JUN 2010 | DOI: 10.1002/hep.23823

  6. Steatohepatitis/ Metabolic Liver Disease

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Original Articles
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Steatohepatitis/ Metabolic Liver Disease
    8. Steatohepatitis/Metabolic Liver Disease
    9. Hepatobiliary Malignancies
    10. Autoimmune, Cholestatic and Biliary Disease
    11. Liver Failure/Cirrhosis/Portal Hypertension
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Rapid Communication
    15. Diagnostic and Therapeutic Advances in Hepatology
    16. Reviews
    17. Hepatology Elsewhere
    18. Image of the Month
    19. Correspondence
    1. You have free access to this content
      A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents (pages 1281–1290)

      Nicola Santoro, Romy Kursawe, Ebe D'Adamo, Daniel J. Dykas, Clarence K. Zhang, Allen E. Bale, Anna M. Calí, Deepak Narayan, Melissa M. Shaw, Bridget Pierpont, Mary Savoye, Derek Lartaud, Samuel Eldrich, Samuel W. Cushman, Hongyu Zhao, Gerald I. Shulman and Sonia Caprio

      Version of Record online: 27 AUG 2010 | DOI: 10.1002/hep.23832

  7. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Original Articles
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Steatohepatitis/ Metabolic Liver Disease
    8. Steatohepatitis/Metabolic Liver Disease
    9. Hepatobiliary Malignancies
    10. Autoimmune, Cholestatic and Biliary Disease
    11. Liver Failure/Cirrhosis/Portal Hypertension
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Rapid Communication
    15. Diagnostic and Therapeutic Advances in Hepatology
    16. Reviews
    17. Hepatology Elsewhere
    18. Image of the Month
    19. Correspondence
    1. You have free access to this content
  8. Hepatobiliary Malignancies

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Original Articles
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Steatohepatitis/ Metabolic Liver Disease
    8. Steatohepatitis/Metabolic Liver Disease
    9. Hepatobiliary Malignancies
    10. Autoimmune, Cholestatic and Biliary Disease
    11. Liver Failure/Cirrhosis/Portal Hypertension
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Rapid Communication
    15. Diagnostic and Therapeutic Advances in Hepatology
    16. Reviews
    17. Hepatology Elsewhere
    18. Image of the Month
    19. Correspondence
    1. You have free access to this content
    2. You have free access to this content
      The Bcl-xL inhibitor, ABT-737, efficiently induces apoptosis and suppresses growth of hepatoma cells in combination with sorafenib (pages 1310–1321)

      Hayato Hikita, Tetsuo Takehara, Satoshi Shimizu, Takahiro Kodama, Minoru Shigekawa, Kyoko Iwase, Atsushi Hosui, Takuya Miyagi, Tomohide Tatsumi, Hisashi Ishida, Wei Li, Tatsuya Kanto, Naoki Hiramatsu and Norio Hayashi

      Version of Record online: 16 JUL 2010 | DOI: 10.1002/hep.23836

    3. You have free access to this content
      Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents (pages 1322–1333)

      Le-Xing Yu, He-Xin Yan, Qiong Liu, Wen Yang, Hong-Ping Wu, Wei Dong, Liang Tang, Yan Lin, Ya-Qin He, Shan-Shan Zou, Chao Wang, Hui-Lu Zhang, Guang-Wen Cao, Meng-Chao Wu and Hong-Yang Wang

      Version of Record online: 29 JUL 2010 | DOI: 10.1002/hep.23845

  9. Autoimmune, Cholestatic and Biliary Disease

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Original Articles
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Steatohepatitis/ Metabolic Liver Disease
    8. Steatohepatitis/Metabolic Liver Disease
    9. Hepatobiliary Malignancies
    10. Autoimmune, Cholestatic and Biliary Disease
    11. Liver Failure/Cirrhosis/Portal Hypertension
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Rapid Communication
    15. Diagnostic and Therapeutic Advances in Hepatology
    16. Reviews
    17. Hepatology Elsewhere
    18. Image of the Month
    19. Correspondence
    1. You have free access to this content
      The potent bile acid sequestrant colesevelam is not effective in cholestatic pruritus: Results of a double-blind, randomized, placebo-controlled trial (pages 1334–1340)

      Edith M. M. Kuiper, Karel J. van Erpecum, Ulrich Beuers, Bettina E. Hansen, H. Bing Thio, Robert A. de Man, Harry L. A. Janssen and Henk R. van Buuren

      Version of Record online: 30 JUN 2010 | DOI: 10.1002/hep.23821

    2. You have free access to this content
      Raised hepatic bile acid concentrations during pregnancy in mice are associated with reduced farnesoid X receptor function (pages 1341–1349)

      Alexandra Milona, Bryn M. Owen, Jeremy F. L. Cobbold, Ellen C. L. Willemsen, Isobel J. Cox, Mohamed Boudjelal, William Cairns, Kristina Schoonjans, Simon D. Taylor-Robinson, Leo W. J. Klomp, Malcolm G. Parker, Roger White, Saskia W. C. van Mil and Catherine Williamson

      Version of Record online: 29 JUL 2010 | DOI: 10.1002/hep.23849

    3. You have free access to this content
  10. Liver Failure/Cirrhosis/Portal Hypertension

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Original Articles
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Steatohepatitis/ Metabolic Liver Disease
    8. Steatohepatitis/Metabolic Liver Disease
    9. Hepatobiliary Malignancies
    10. Autoimmune, Cholestatic and Biliary Disease
    11. Liver Failure/Cirrhosis/Portal Hypertension
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Rapid Communication
    15. Diagnostic and Therapeutic Advances in Hepatology
    16. Reviews
    17. Hepatology Elsewhere
    18. Image of the Month
    19. Correspondence
    1. You have free access to this content
      Use of sirolimus in liver transplant recipients with renal insufficiency: A systematic review and meta-analysis (pages 1360–1370)

      Sumeet K. Asrani, Michael D. Leise, Colin P. West, M. Hassan Murad, Rachel A. Pedersen, Patricia J. Erwin, Jianmin Tian, Russell H. Wiesner and W. Ray Kim

      Version of Record online: 16 JUL 2010 | DOI: 10.1002/hep.23835

  11. Liver Injury/Regeneration

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Original Articles
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Steatohepatitis/ Metabolic Liver Disease
    8. Steatohepatitis/Metabolic Liver Disease
    9. Hepatobiliary Malignancies
    10. Autoimmune, Cholestatic and Biliary Disease
    11. Liver Failure/Cirrhosis/Portal Hypertension
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Rapid Communication
    15. Diagnostic and Therapeutic Advances in Hepatology
    16. Reviews
    17. Hepatology Elsewhere
    18. Image of the Month
    19. Correspondence
    1. You have free access to this content
      Growth arrest–specific protein 6 is hepatoprotective against murine ischemia/reperfusion injury (pages 1371–1379)

      Laura Llacuna, Cristina Bárcena, Lola Bellido-Martín, Laura Fernández, Milica Stefanovic, Montserrat Marí, Carmen García-Ruiz, José C. Fernández-Checa, Pablo García de Frutos and Albert Morales

      Version of Record online: 20 AUG 2010 | DOI: 10.1002/hep.23833

    2. You have free access to this content
      Programmed death-1/B7-H1 negative costimulation protects mouse liver against ischemia and reperfusion injury (pages 1380–1389)

      Haofeng Ji, Xiuda Shen, Feng Gao, Bibo Ke, Maria Cecilia S. Freitas, Yoichiro Uchida, Ronald W. Busuttil, Yuan Zhai and Jerzy W. Kupiec-Weglinski

      Version of Record online: 29 JUL 2010 | DOI: 10.1002/hep.23843

  12. Liver Biology/Pathobiology

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Original Articles
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Steatohepatitis/ Metabolic Liver Disease
    8. Steatohepatitis/Metabolic Liver Disease
    9. Hepatobiliary Malignancies
    10. Autoimmune, Cholestatic and Biliary Disease
    11. Liver Failure/Cirrhosis/Portal Hypertension
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Rapid Communication
    15. Diagnostic and Therapeutic Advances in Hepatology
    16. Reviews
    17. Hepatology Elsewhere
    18. Image of the Month
    19. Correspondence
    1. You have free access to this content
      CX3CL1-CX3CR1 interaction prevents carbon tetrachloride-induced liver inflammation and fibrosis in mice (pages 1390–1400)

      Tomonori Aoyama, Sayaka Inokuchi, David A. Brenner and Ekihiro Seki

      Version of Record online: 11 JUN 2010 | DOI: 10.1002/hep.23795

    2. You have free access to this content
      A novel role for thyroid-stimulating hormone: Up-regulation of hepatic 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase expression through the cyclic adenosine monophosphate/protein kinase A/cyclic adenosine monophosphate–responsive element binding protein pathway (pages 1401–1409)

      Limin Tian, Yongfeng Song, Mingzhao Xing, Wei Zhang, Guang Ning, Xiaoying Li, Chunxiao Yu, Chengkong Qin, Jun Liu, Xingsong Tian, Xianglan Sun, Rui Fu, Lin Zhang, Xiujuan Zhang, Yan Lu, Jianwen Zou, Laicheng Wang, Qingbo Guan, Ling Gao and Jiajun Zhao

      Version of Record online: 11 JUN 2010 | DOI: 10.1002/hep.23800

    3. You have free access to this content
      Liver-specific β-catenin knockout mice have bile canalicular abnormalities, bile secretory defect, and intrahepatic cholestasis (pages 1410–1419)

      Tzu-Hsuan Yeh, Lindsay Krauland, Vijay Singh, Baobo Zou, Prathab Devaraj, Donna B. Stolz, Jonathan Franks, Satdarshan P. S. Monga, Eizaburo Sasatomi and Jaideep Behari

      Version of Record online: 11 JUN 2010 | DOI: 10.1002/hep.23801

    4. You have free access to this content
      Role and cellular source of nicotinamide adenine dinucleotide phosphate oxidase in hepatic fibrosis (pages 1420–1430)

      Samuele De Minicis, Ekihiro Seki, Yong-Han Paik, Christoph H. Österreicher, Yuzo Kodama, Johannes Kluwe, Luciano Torozzi, Katsumi Miyai, Antonio Benedetti, Robert F. Schwabe and David A. Brenner

      Version of Record online: 11 JUN 2010 | DOI: 10.1002/hep.23804

    5. You have free access to this content
      Liver-enriched transcription factors regulate MicroRNA-122 that targets CUTL1 during liver development (pages 1431–1442)

      Hui Xu, Jie-Hua He, Zhen-Dong Xiao, Qian-Qian Zhang, Yue-Qin Chen, Hui Zhou and Liang-Hu Qu

      Version of Record online: 30 JUN 2010 | DOI: 10.1002/hep.23818

    6. You have free access to this content
      Paracrine signals from mesenchymal cell populations govern the expansion and differentiation of human hepatic stem cells to adult liver fates (pages 1443–1454)

      Yunfang Wang, Hsin-Lei Yao, Cai-Bin Cui, Eliane Wauthier, Claire Barbier, Martin J. Costello, Nicholas Moss, Mitsuo Yamauchi, Marnisa Sricholpech, David Gerber, Elizabeth G. Loboa and Lola M. Reid

      Version of Record online: 30 JUN 2010 | DOI: 10.1002/hep.23829

    7. You have free access to this content
      Improved glycemic control with colesevelam treatment in patients with type 2 diabetes is not directly associated with changes in bile acid metabolism (pages 1455–1464)

      Gemma Brufau, Frans Stellaard, Kris Prado, Vincent W. Bloks, Elles Jonkers, Renze Boverhof, Folkert Kuipers and Elizabeth J. Murphy

      Version of Record online: 19 AUG 2010 | DOI: 10.1002/hep.23831

    8. You have free access to this content
      Phosphoinositide 3-kinase/protein kinase B signaling pathway is involved in estradiol 17β-d-glucuronide–induced cholestasis: Complementarity with classical protein kinase c (pages 1465–1476)

      Andrea C. Boaglio, Andrés E. Zucchetti, Enrique J. Sánchez Pozzi, José M. Pellegrino, Justina Elena Ochoa, Aldo D. Mottino, Mary Vore, Fernando A. Crocenzi and Marcelo G. Roma

      Version of Record online: 29 JUL 2010 | DOI: 10.1002/hep.23846

  13. Rapid Communication

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Original Articles
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Steatohepatitis/ Metabolic Liver Disease
    8. Steatohepatitis/Metabolic Liver Disease
    9. Hepatobiliary Malignancies
    10. Autoimmune, Cholestatic and Biliary Disease
    11. Liver Failure/Cirrhosis/Portal Hypertension
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Rapid Communication
    15. Diagnostic and Therapeutic Advances in Hepatology
    16. Reviews
    17. Hepatology Elsewhere
    18. Image of the Month
    19. Correspondence
    1. You have free access to this content
      P2Y13 receptor is critical for reverse cholesterol transport (pages 1477–1483)

      Aurélie C. Fabre, Camille Malaval, Abduelhakem Ben Addi, Céline Verdier, Véronique Pons, Nizar Serhan, Laeticia Lichtenstein, Guillaume Combes, Thierry Huby, François Briand, Xavier Collet, Niels Nijstad, Uwe J.F. Tietge, Bernard Robaye, Bertrand Perret, Jean-Marie Boeynaems and Laurent O. Martinez

      Version of Record online: 9 SEP 2010 | DOI: 10.1002/hep.23897

  14. Diagnostic and Therapeutic Advances in Hepatology

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Original Articles
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Steatohepatitis/ Metabolic Liver Disease
    8. Steatohepatitis/Metabolic Liver Disease
    9. Hepatobiliary Malignancies
    10. Autoimmune, Cholestatic and Biliary Disease
    11. Liver Failure/Cirrhosis/Portal Hypertension
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Rapid Communication
    15. Diagnostic and Therapeutic Advances in Hepatology
    16. Reviews
    17. Hepatology Elsewhere
    18. Image of the Month
    19. Correspondence
    1. You have free access to this content
      Drug therapy: Rifaximin (pages 1484–1488)

      Jasmohan S. Bajaj and Oliviero Riggio

      Version of Record online: 29 JUL 2010 | DOI: 10.1002/hep.23866

  15. Reviews

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Original Articles
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Steatohepatitis/ Metabolic Liver Disease
    8. Steatohepatitis/Metabolic Liver Disease
    9. Hepatobiliary Malignancies
    10. Autoimmune, Cholestatic and Biliary Disease
    11. Liver Failure/Cirrhosis/Portal Hypertension
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Rapid Communication
    15. Diagnostic and Therapeutic Advances in Hepatology
    16. Reviews
    17. Hepatology Elsewhere
    18. Image of the Month
    19. Correspondence
    1. You have free access to this content
      The biliary HCO3 umbrella: A unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies (pages 1489–1496)

      Ulrich Beuers, Simon Hohenester, Lucas J. Maillette de Buy Wenniger, Andreas E. Kremer, Peter L. M. Jansen and Ronald P. J. Oude Elferink

      Version of Record online: 16 JUN 2010 | DOI: 10.1002/hep.23810

    2. You have free access to this content
      Is sexual contact a major mode of hepatitis C virus transmission? (pages 1497–1505)

      Rania A. Tohme and Scott D. Holmberg

      Version of Record online: 16 JUN 2010 | DOI: 10.1002/hep.23808

  16. Hepatology Elsewhere

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Original Articles
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Steatohepatitis/ Metabolic Liver Disease
    8. Steatohepatitis/Metabolic Liver Disease
    9. Hepatobiliary Malignancies
    10. Autoimmune, Cholestatic and Biliary Disease
    11. Liver Failure/Cirrhosis/Portal Hypertension
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Rapid Communication
    15. Diagnostic and Therapeutic Advances in Hepatology
    16. Reviews
    17. Hepatology Elsewhere
    18. Image of the Month
    19. Correspondence
    1. You have free access to this content
      The MAP3K TAK1: A chock block to liver cancer formation (pages 1506–1509)

      Yann Malato and Holger Willenbring

      Version of Record online: 28 SEP 2010 | DOI: 10.1002/hep.23878

    2. You have free access to this content
  17. Image of the Month

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Original Articles
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Steatohepatitis/ Metabolic Liver Disease
    8. Steatohepatitis/Metabolic Liver Disease
    9. Hepatobiliary Malignancies
    10. Autoimmune, Cholestatic and Biliary Disease
    11. Liver Failure/Cirrhosis/Portal Hypertension
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Rapid Communication
    15. Diagnostic and Therapeutic Advances in Hepatology
    16. Reviews
    17. Hepatology Elsewhere
    18. Image of the Month
    19. Correspondence
    1. You have free access to this content
      Biliary papillomatosis (pages 1512–1514)

      Lieve Braeye and Ruben Vanheste

      Version of Record online: 28 SEP 2010 | DOI: 10.1002/hep.23914

  18. Correspondence

    1. Top of page
    2. Master's Perspective
    3. Editorials
    4. Original Articles
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Steatohepatitis/ Metabolic Liver Disease
    8. Steatohepatitis/Metabolic Liver Disease
    9. Hepatobiliary Malignancies
    10. Autoimmune, Cholestatic and Biliary Disease
    11. Liver Failure/Cirrhosis/Portal Hypertension
    12. Liver Injury/Regeneration
    13. Liver Biology/Pathobiology
    14. Rapid Communication
    15. Diagnostic and Therapeutic Advances in Hepatology
    16. Reviews
    17. Hepatology Elsewhere
    18. Image of the Month
    19. Correspondence
    1. You have free access to this content
      Noninvasive diagnostic criteria for hepatocellular carcinoma: A boat that leaks like a sieve (pages 1515–1516)

      Giorgia Ghittoni, Eugenio Caturelli and Sandro Rossi

      Version of Record online: 29 JUL 2010 | DOI: 10.1002/hep.23864

    2. You have free access to this content
      Reply: (pages 1516–1517)

      Alejandro Forner, Ramón Vilana and Jordi Bruix

      Version of Record online: 5 AUG 2010 | DOI: 10.1002/hep.23884

    3. You have free access to this content
    4. You have free access to this content
      Reply: (page 1518)

      Hui Xu and Liang-Hu Qu

      Version of Record online: 5 AUG 2010 | DOI: 10.1002/hep.23888

    5. You have free access to this content
    6. You have free access to this content
      Reply: (page 1519)

      Elizabeth K. Speliotes, Joseph M. Massaro, Christopher J. O'Donnell and Caroline S. Fox

      Version of Record online: 5 AUG 2010 | DOI: 10.1002/hep.23887

    7. You have free access to this content
    8. You have free access to this content
      Reply: (pages 1520–1521)

      Maria Buti and Rafael Esteban

      Version of Record online: 28 SEP 2010 | DOI: 10.1002/hep.23951

    9. You have free access to this content
      Hepatic steatosis with hepatitis B virus/hepatitis C virus dual infection (pages 1521–1522)

      Chao-Hung Hung, Chuan-Mo Lee, Sheng-Nan Lu, Jing-Houng Wang, Chien-Hung Chen and Tsung-Hui Hu

      Version of Record online: 14 MAY 2010 | DOI: 10.1002/hep.23740

    10. You have free access to this content
      Smoking is associated with histological severity in nonalcoholic steatohepatitis (pages 1522–1523)

      Emmanuel A. Tsochatzis and George V. Papatheodoridis

      Version of Record online: 14 MAY 2010 | DOI: 10.1002/hep.23751

    11. You have free access to this content
      Health-related quality of life and sorafenib (page 1523)

      Giancarlo Spinzi and Natalia Terreni

      Version of Record online: 14 MAY 2010 | DOI: 10.1002/hep.23756

    12. You have free access to this content
      Activation of the mammalian target of rapamycin signaling pathway in hepatocellular carcinoma (page 1524)

      Ishwaria M. Subbiah, Robert E. Brown and Michael B. Fallon

      Version of Record online: 2 AUG 2010 | DOI: 10.1002/hep.23763

    13. You have free access to this content
      Hepatitis C treatment in an urban population (pages 1524–1525)

      Anna Christina Dela Cruz, Ellen Engelson, Gabriel Ionescu, Veronika Dubrovskaya and Donald Kotler

      Version of Record online: 18 MAY 2010 | DOI: 10.1002/hep.23770

    14. You have free access to this content

SEARCH

SEARCH BY CITATION